Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of CRH on Duodenal Markers and Gastric Function
NCT05071781Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- May 2021
- Primary completion
- Dec 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of corticotrophin-releasing hormone in gastrointestinal motility disorder, sponsored by UZ Leuven. Started May 2021; status: completed.
02
Drugs
corticotrophin-releasing hormone
03
Conditions
gastrointestinal motility disorder
Beyond the preview
Go deeper on NCT05071781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05071781.